Literature DB >> 11819237

Establishment of a nonradioactive assay for 2'-5' oligoadenylate synthetase and its application in chronic hepatitis C patients receiving interferon-alpha

Wen-Bin Tong, Chun-Ying Zhang, Bai-Fang Feng, Qi-Min Tao.   

Abstract

AIM:To establish a nonradioactive assay for 2'-5' oligoadenylate synthetase (2-5 AS) and to measure the 2-5AS in peripheral blood mononuclear cell (PBMC) extracts of patients with chronic hepatitis C before IFN-alphainjection, 24 hours and one month after the first injection.
METHODS: 2-5AS in cell extracts of PBMCs from 10 normal persons and 15 chronic hepatitis C patients were determined with PEI cellulose thin-layer chromatography.
RESULTS: The assay of 2-5AS in human PBMC was found to be rapid, sensitive, specific and reliable. The 2-5AS activity of PBMC in normal persons was in a quite low level (2.0%), and it was increased about ten-folds after stimulation of IFN (19.7%), (P < 0.01). In 15 chronic hepatitic C patients, the basal levels of 2-5AS before IFN treatment were higher than those of normal persons, being much higher in the group showing poor response to IFN treatment, but 24h after the first injection of IFN-alphathe 2-5AS level showed a more rapid and much greater rise in those patients with a good response.
CONCLUSION: 2-5AS may be a useful parameter of biological response during the IFN therapy.

Entities:  

Year:  1998        PMID: 11819237      PMCID: PMC4767771          DOI: 10.3748/wjg.v4.i1.70

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  10 in total

1.  Incorporation in vitro of labeled amino acids into proteins of rabbit reticulocytes.

Authors:  H BORSOOK; C L DEASY; A J HAAGENSMIT; G KEIGHLEY; P H LOWY
Journal:  J Biol Chem       Date:  1952-05       Impact factor: 5.157

2.  Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B.

Authors:  M Shindo; T Okuno; M Matsumoto; M Takeda; T Takino; J Sokawa; A Iwata; Y Sokawa
Journal:  Hepatology       Date:  1988 Mar-Apr       Impact factor: 17.425

3.  The interferon-induced enzyme oligo-isoadenylate synthetase: rapid determination of its in vitro products.

Authors:  G Merlin; M Revel; D Wallach
Journal:  Anal Biochem       Date:  1981-01-01       Impact factor: 3.365

4.  (2'-5') Oligoadenylate synthetase in the maturation of rabbit reticulocytes.

Authors:  D Ferbus; J Justesen; H Bertrand; M N Thang
Journal:  Mol Cell Biochem       Date:  1984-04       Impact factor: 3.396

5.  Fractionation and characterization of 2',5'-oligoadenylates by polyacrylamide gel electrophoresis: an alternative method for assaying 2',5'-oligoadenylate synthetase.

Authors:  M B Miele; D K Liu; N C Kan
Journal:  J Interferon Res       Date:  1991-02

6.  A sensitive immunoenzymometric assay for 2',5'-oligoadenylate. Detection of elevated 2',5'-oligoadenylate synthetase in human peripheral mononuclear cells.

Authors:  M I Johnston; O T Preble; J Imai; H Jacobsen; P F Torrence
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

7.  2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B.

Authors:  M Furuta; K Akashi; Y Nakamura; K Matsumoto; H Yamaguchi; S Takamatsu; T Shimizu
Journal:  J Interferon Res       Date:  1987-02

8.  Measurement of 2',5'-oligoadenylate synthetase in patients receiving interferon-alpha.

Authors:  J A Merritt; E C Borden; L A Ball
Journal:  J Interferon Res       Date:  1985

9.  Monitoring of interferon therapy by assay of (2'--5') oligo-isoadenylate synthetase in human peripheral white blood cells.

Authors:  A Schattner; G Merlin; D Wallach; H Rosenberg; T Bino; T Hahn; S Levin; M Revel
Journal:  J Interferon Res       Date:  1981

10.  Methods for the determination of the interferon-induced enzyme 2'-5' oligoadenylate synthetase in mononuclear blood cells.

Authors:  G Bruchelt; J Beck; K Schilbach-Stückle; E Koscielniak; J Treuner; D Niethammer
Journal:  J Clin Chem Clin Biochem       Date:  1987-12
  10 in total
  5 in total

1.  Preliminary results of Thymosin-a1 versus interferon-alpha-treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B.

Authors:  L Zhuang; J You; B Z Tang; S Y Ding; K H Yan; D Peng; Y M Zhang; L Zhang
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

2.  A randomized controlled clinical trial on the treatment of Thymosin a1 versus interferon-alpha in patients with hepatitis B.

Authors:  J You; L Zhuang; B Z Tang; W B Yang; S Y Ding; W Li; R X Wu; H L Zhang; Y M Zhang; S M Yan; L Zhang
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

3.  mIL-2R, T cell subsets & hepatitis C.

Authors:  Chao-Pin Li; Ke-Xia Wang; Jian Wang; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

4.  Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study.

Authors:  Jing You; Lin Zhuang; Hong-Ying Cheng; Shou-Ming Yan; Lan Yu; Jun-Hua Huang; Bao-Zhang Tang; Meng-Ling Huang; Yong-Liang Ma; Virasakdi Chongsuvivatwong; Hutcha Sriplung; Alan Geater; Yan-Wei Qiao; Rong-Xue Wu
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

5.  Distribution of nitric oxide synthase in stomach myenteric plexus of rats.

Authors:  X Peng; J B Feng; H Yan; Y Zhao; S L Wang
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.